LVMH shares slump as Q1 sales come short of expectations; stock downgraded at MS

Published 14/04/2025, 17:20
Updated 15/04/2025, 08:34
© Reuters.

Investing.com - The ADRs of luxury goods maker LVMH Moet Hennessy Louis Vuitton SA (EPA:LVMH) ADR (OTC:LVMUY) fell more than 6% on Monday after the company reported that total first quarter organic sales fell 3% to EUR 20.311 billion.  Analysts had expected growth of 2%.

"Europe once again achieved growth on a constant consolidation scope and currency basis," the company stated. "The United States saw a slight decline, despite a good performance in Fashion & Leather Goods and in Watches & Jewelry. Japan was down with respect to the first quarter of 2024, which had been boosted by strong growth in Chinese consumer spending in the country. The rest of Asia saw trends comparable to 2024."

Sales in its all-important fashion & Leather Goods segment fell 5% to EUR 10.108 billion.

Sales in the Wines & Spirits group fell 9%. Champagne was down slightly, while Cognac was held back by weaker demand in China and the United States.

The Perfumes & Cosmetics business group saw sales fall 1% organically.

The Watches & Jewelry business group saw sales flat on a year-over-year basis.

In Selective Retailing, sales were down 1% on an organic basis.

Morgan Stanley (NYSE:MS) analysts downgraded LVMH shares to Equal Weight after the report, noting they expect another decline in sales for the second quarter of 2025. They forecast organic sales growth of -3%, down from a previous estimate of +2%.

If this projection materializes, it would mark the first time in over three decades that the Fragrance & Luxury Goods division records four consecutive quarters of sales contraction. 

"The difference this time is that demand from China is a major drag and the industry is now facing a softer macro environment worldwide after having raised prices significantly,
unlike in 2008 & 2009 and unlike in 2020," Morgan Stanley analysts said in a note. 

"Hence we expect LVMH and industry top line is likely to remain anemic over the next 12 months," they added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.